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Protein Expression and Purification.DNA fragments of the Nup214
NTD and the Nup214 NTD 1–405, encompassing residues 1 to
450 and 1 to 405, respectively, were amplified by PCR from a
human Nup214 cDNA construct (KIAA0023) and cloned in a
pET28a vector (pET28a-PreS) modified to contain a PreScission
protease-cleavable N-terminal hexa-histidine tag (1). For
Nup214 NTD 6D7A, residues 343 to 361 were replaced by a
flexible linker with the sequence GGSGG and cloned in the
pET28a-PreS vector, as described above. A DNA fragment
encompassing residues 343 to 361 of the Nup214 NTD 6D7A
loop and followed by a hexa-histidine tag was cloned into the
pGEX-6P1 vector (GE Healthcare). DNA fragments of the
full-length human Ddx19, and a Dxd19 fragment, encompassing
residues 1 to 300 (Ddx19 NTD), were amplified from HeLa cell
cDNA, and cloned in the pET28a-PreS vector. Mutants of the
Nup214 NTD and Ddx19 were generated using Quikchange
site-directed mutagenesis (Stratagene). The details of the ex-
pression constructs and the mutants of Nup214 and Ddx19 are
listed in Tables S2–S4.
The different constructs of Nup214 and the GST-6D7A-HIS
loop fusion protein were expressed and purified as described for
the Nup214 NTD (2). For expression of Ddx19, Ddx19 NTD, and
Ddx19 mutants, E. coli BL21(DE3) cells (Stratagene) were
grown at 37°C to an OD600 of 0.6 and induced with 450 M
isopropyl--D-thio-galactoside at 17°C for 9 h. Cells were har-
vested by centrifugation and resuspended in a lysis buffer
containing 20 mM Tris, pH 8.0, 500 mM NaCl, 5 mM -mer-
captoethanol, 1 mM PMSF, and Complete EDTA-free protease
inhibitor mixture tablets (Roche). The cells were lysed with a cell
disrupter (Avestin), and the lysate was clarified by centrifugation
at 40,000 g for 90 min. The lysate was then loaded onto a Ni-NTA
column (Qiagen) and eluted via an imidazole gradient. Fractions
containing hexa-histidine tagged Ddx19 were pooled, and glyc-
erol was added to a final concentration of 10% (vol/vol). The
protein was further purified after cleavage of the hexa-histidine
tag with PreScission protease (GE Healthcare) by size exclusion
chromatography on a 16/60 Superdex 200 column (GE Health-
care) that was equilibrated in a buffer containing 20mMTris, pH
8.0, 100 mM KCl, 10% glycerol, and 5 mM DTT.
For complex formation, Nup214 NTD was incubated with an
equimolar amount of either Ddx19 or Ddx19 NTD and purified
by size exclusion chromatography on a 16/60 Superdex 200
column (GE Healthcare) that was equilibrated in a buffer
containing 20 mM Tris pH 8.0, 100 mM KCl, 5% glycerol, 5 mM
DTT and 0.5 mMMgADP (Spectrum Chemical). The fractions
containing the complex were pooled and concentrated to 40
mg/mL for crystallization.
Protein Interaction Analysis. Protein interaction experiments were
carried out on a Superdex 200 10/300 GL gel filtration column
(GE Healthcare) that was equilibrated in a buffer containing 20
mMTris, pH 8.0, 100 mMKCl, 10% (vol/vol) glycerol, and 5 mM
DTT. Complexes were formed by incubating 1 mg of the various
purified proteins, their mutants, or variants for 30 min at 4°C.
Complex formation was monitored by injection of the preincu-
bated proteins and the recombinant purified proteins in isola-
tion. All proteins were analyzed under the same buffer condi-
tions, and complex formation was confirmed by SDS/PAGE of
the eluted fractions followed by Coomassie brilliant blue stain-
ing.
Peptide Binding Assay.A peptide array composed of 20-mers with
an offset of 3 residues covering the entire sequence of human
Ddx19 was synthesized and immobilized onto a nitrocellulose
membrane (Rockefeller University Proteomics Resource Cen-
ter). The peptide array was blocked for 7 h in TBS-Tween buffer
supplemented with 5% (wt/vol) milk powder and washed 3 times
for 10 min in TBS-Tween buffer followed by a single wash step
in transport buffer (20 mM Hepes-KOH, pH 7.5, 110 mM
potassium acetate, 2 mM MgCl2, 0.1% Tween-20). The peptide
array was then incubated with the in vitro transcribed, translated,
and [35S]-methionine-labeled Nup214 NTD (Promega, TnT
quick coupled Transcription/Translation system) in transport
buffer at 4°C. Before detection by autoradiography, the mem-
brane was washed 4 times for 10 min with transport buffer.
Generation of a Ddx19 Homology Model. Based on the structure of
the M. jannaschii DEAD-box helicase MjDEAD (PDB code
1HV8) (3) and a sequence alignment of 10 eukaryotic Ddx19
homologs (Fig. S1), we generated a homology model for human
Ddx19 using MODELLER (4). Although the central core region
that contains the 10 conserved sequence motifs aligned without
major sequence gaps, the Ddx19-specific N-terminal sequence is
not conserved in MjDEAD. Hence, we were able to generate a
model for the core region, but we are unable to model the unique
N-terminal extension of Ddx19.
Crystallization and Data Collection. Crystals of human Nup214
NTD•Ddx19 and Nup214 NTD•Ddx19 NTD were grown at
21°C in hanging drops containing 1 L of the protein (40
mg/mL), which contained 0.5 mM Mg•ADP and 1 L of a
reservoir solution. Crystals of Nup214 NTD•Ddx19 and Nup214
NTD•Ddx19 NTD grew in 0.1MCHES, pH 9.5, 30% PEG 3000,
and in 0.1 M sodium acetate, pH 4.2–4.5, 0.8 M sodium
di-hydrogen phosphate, and 1.2 M di-potassium hydrogen phos-
phate, respectively. For cryoprotection, Nup214 NTD•Ddx19
and Nup214 NTD•Ddx19 NTD crystals were stabilized and
cryo-protected in 0.1 M CHES, pH 9.5, 30% (vol/vol) PEG 3000,
supplemented with 10% (vol/vol) glycerol, and in 0.1 M sodium
acetate, pH 4.2, 0.8 M sodium di-hydrogen phosphate, 1.2 M
di-potassium phosphate, supplemented with 20% (vol/vol) glyc-
erol, respectively, and flash frozen in liquid nitrogen-cooled
liquid propane. X-ray diffraction data were collected at beam-
lines 8.2.1 and 8.2.2 at the Advanced Light Source, Lawrence
Berkeley National Laboratory. X-ray intensities were processed
and integrated using the HKL2000 denzo/scalepack package (5),
and the CCP4 program package was used for subsequent cal-
culations (6).
Structure Determination. The structure of the Nup214
NTD•Ddx19 was solved by molecular replacement, using the
coordinates of the Nup214 NTD (2) as a search model in
PHASER (7). This resulting electron density map was of high
quality and clearly revealed additional density for the N-terminal
domain of Ddx19. A model was built with the program O (8) and
refined with CNS (9). No electron density was observed for the
N-terminal 8 and C-terminal 22 residues of Nup214, and the
N-terminal 69 and C-terminal 181 residues that encompass
the entire C-terminal RecA-like domain (domain 2) of Ddx19.
These residues are presumed to be disordered, and, therefore,
have been omitted from the final model. The final model
contains residues 9 to 428 and 70 to 298 of Nup214 and Ddx19,
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respectively, and has been refined to 3.2 Å resolution with an
Rcryst factor of 24.9% and an Rfree factor of 28.3%.
The structure of the Nup214 NTD•Ddx19 NTD complex was
determined using the coordinates of the refined Nup214
NTD•Ddx19 complex as a search model in PHASER (7). The
final rounds of refinement were carried out with REFMAC,
using the TLS option (10). The final model contains residues 8
to 428 and 69 to 300 of Nup214 and Ddx19, respectively, and has
been refined to 2.5 Å resolution with anRcryst factor of 19.9% and
an Rfree factor of 24.2%. The stereochemical quality of the final
models was assessed with PROCHECK (11) and Molprobity
(12). Met-291 in Nup214 is the only outlier in the Nup214
NTD•Ddx19 NTD structure. However, this residue is well
defined in the electron density map and is located in a canonical
-turn type II’ (13). Data collection and refinement statistics are
shown in the Table S1.
Immunofluorescence Confocal Microscopy. For immunofluores-
cence, Ddx19, Nup214 NTD, and their mutants and variants
were cloned into the pCMV-HA vector (Clontech) containing a
C-terminal HA-tag. The details of the Nup214 and Ddx19
constructs are listed in Table S4. Mammalian cell culture and
transfection of HeLa cells were performed as described in ref.
14. HeLa cells were washed in PBS and fixed for 20 min in 4%
PFA (Wako) at room temperature (RT) and then washed twice
with PBS again. Cells were then permeabilized with 0.3%
Digitonin (Electron Microscope Sciences) and 1% BSA (Sigma)
in PBS for 10 min at RT. Cells were blocked with 3%BSA in PBS
for 20 min.
For Ddx19 variants, the cells were incubated with -HA (at a
dilution of 1:2,000, Abcam) for 1 h at RT. The cells were washed
twice with PBS and were incubated with secondary antibody
(goat -rabbit Alexa Fluor 488, at a dilution of 1:2,000, Invitro-
gen) for 1 h at RT. The cells were further incubated with
-mAb414 (at a dilution 1:1,000, Covance) for 1 h at RT, washed
twice with PBS, incubated with secondary antibodies (goat
-mouse Rodamine-Red X, at a dilution of 1:1,000, Invitrogen)
for 1 h at RT and mounted onto cover slips with ProLong Gold
Antifade reagent (Invitrogen). Samples were examined on a
Zeiss LSM5 EXCITER confocal microscope, and all images
acquired by using an aplan-Apochromat 63X with an 1.4-n.a.
objective.
For Nup214 variants, the cells were costained with a mouse
-HA antibody (at a dilution of 1:1,000, Covance) and a rabbit
-Nup358 antibody (at a dilution of 1:500) (15) for 1 h at RT. The
cells were washed 3 times with PBS, incubated with secondary
antibodies for 1 h at RT (goat -rabbit Alexa Fluor 488, goat
-rabbit Alexa Fluor 647; both at a dilution of 1:200, Molecular
Probes), washed 3 times with PBS, and mounted in Fluoromount
G (Electron Microscopy Sciences). The samples were examined
using a Leica spectral confocal microscope (model TCS SP).
Illustrations and Figures. Figures were generated using PyMOL
(www.pymol.org). The molecular surfaces were calculated using
MSMS (16), and the electrostatic potential was calculated using
APBS (17). Sequence alignments were generated using ClustalX
(18) and colored with Alscript (19).
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Fig. S1. Multispecies sequence alignment of Ddx19 homologs. The overall sequence conservation at each position is shaded in a color gradient from yellow
(60% similarity) to dark red (100% identity), using the Blosum62 weighting algorithm. The secondary structure of Ddx19 as observed in the Nup214 NTD•Ddx19
structure is shown above the alignment. The residue numbering is relative to H. sapiens Ddx19 and gray boxes below the alignment indicate the position of the
9 conserved DEAD-box helicase motifs. As a reference, the primary sequence of theM. janaschiiDEAD-box protein MjDEAD is aligned with the Ddx19 homologs.
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Fig. S2. Salt dependence of the Nup214–Ddx19 interaction. Gel filtration profiles of the Nup214•Ddx19 complex at identical protein complex concentrations
of 50 M and the indicated salt concentrations. The elution positions for molecular weight standards are indicated.
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Fig. S3. Comparison of the 6D7A loops of the human Nup214 and the yeast Nup159 -propeller domains. (A) Structural alignment of the 6D7A loops of the
homologous human and yeast -propellers. The surface of the Nup214 -propeller domain omitting the 6D7A loop is shown in a gray surface rendition. The
C-traces of the 6D7A loop of Nup214 (red) and Nup159 (blue) are shown in coil representation and side chains in ball-and-stick representation. For clarity, only
the Nup214 residues are numbered. The localizations of the Nup159 mutants V323E and I326E that abolish complex formation with the yeast Dbp5 helicase are
indicated by green dots. (B) Structure-based sequence alignment of the Nup214 and Nup159 6D7A loops. The secondary structure and residue numbering are
indicated above and below the sequence for Nup214 and Nup159, respectively. The localization of the Nup159 double mutant V323E/I326E is labeled by green
dots, and conserved residues are highlighted. The residues of the 6D7A loop that are deleted in the Nup214 NTD 1, 2, and 3 variants are indicated.
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Fig. S4. Analysis of the Nup214•Ddx19 interaction by peptide array. (A) Ddx19 peptide array probed with the radioactively labeled Nup214 NTD. The 5
identified regions containing at least 4 consecutive peptide spots are numbered I to V and are indicated by a red box. (B) Domain structures of Ddx19 and the
M. jannaschii DEAD-box protein MjDEAD, displaying the 9 conserved sequence motifs as indicated in Fig. S1. The 5 identified regions and their corresponding
residues are indicated. (C) Homology model of Ddx19 in surface representation based on MjDEAD (PDB code 1HV8) (3). Identified peptides were mapped onto
the surface and colored in red. The residue numbering is relative to human Ddx19.
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Fig. S5. Alanine-scanning mutagenesis of Ddx19. Homology model of Ddx19 illustrating the approximate location of mutated Ddx19 surface residues. Alanine
mutants that were capable of interacting with Nup214 are shown in yellow, and mutant R259A, which is incapable of interacting with Nup214, is shown in red.
The residue numbering is relative to human Ddx19.
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Fig. S6. In vivo localization of Nup214 and Nup214 fragments. (A) The domain organization of Nup214 and the various Nup214 fragments are indicated. (B)
HeLa cells were transfected with Nup214 and Nup214 fragments containing a C-terminal HA-tag and analyzed with confocal microscopy. The cellular localization
of the HA-tagged Nup214 proteins was detected with an-HA antibody (green). The polyclonal-Nup358 antibody was used as a reference for nuclear envelope
staining (red). The merged image is shown on the right.
Napetschnig et al. www.pnas.org/cgi/content/short/0813267106 8 of 12
Table S1. Crystallographic analysis
Crystal 1 native Crystal 2 native
Contents
Nup214 Nup214 NTD Nup214 NTD
Ddx19 Ddx19, residues 1–300 Ddx19, residues 1–479
Data collection
Synchrotron ALS ALS
Beamline BL8.2.2 BL8.2.1
Space group P212121 P21
Cell dimensions, Å
a 59.5 61.4
b 115.4 112.9
c 143.5 142.6
Cell dimensions, °
 90 90
 90 89.9
 90 90
Wavelength, Å 1.0000 0.9795
Resolution, Å 50.0–2.5 50.0–3.2
Rsym,* % 10.5 (68.7) 11.3 (39.5)
I/I* 25.0 (2.7) 14.3 (3.6)
Completeness,* % 98.6 (89.9) 91.3 (70.9)
Redundancy* 13.8 (10.8) 6.8 (5.9)
Refinement
Resolution, Å 50.0–2.5 50.0–3.2
No. reflections
Total 29,350 28,125
Test set, % 1,528 (4.9) 1,504 (5.1)
Rwork/Rfree, % 19.9/24.2 24.9/28.3
No. atoms 5,183 10,218
Protein 5,118 10,164
Ligand/ion 33 54
Water 32 0
B factors 59 86
Protein 58 86
Ligand/ion 60 89
Water 49 N.A.
rmsd
Bond lengths, Å 0.014 0.013
Bond angles, ° 1.5 1.5
Ramachandran statistics
Most favored, % 89.7 82.1
Additionally allowed, % 9.4 16.5
Generously allowed, % 0.7 1.3
Disallowed, % 0.2 0.0
*Highest-resolution shells are shown in parentheses.
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Table S2. Nup214 NTD mutants
Deletions Alanine mutants
Nup214 NTD Nup214 NTD L343A
Nup214 NTD 1–405 Nup214 NTD D345A
Nup214 NTD 6D7A Nup214 NTD S346A
Nup214 NTD 1 Nup214 NTD R348A
Nup214 NTD 2 Nup214 NTD E350A
Nup214 NTD 3 Nup214 NTD V353A
GST-6D7A-His6 Nup214 NTD T354A
Nup214 NTD D355A
Nup214 NTD K356A
Nup214 NTD S357A
Nup214 NTD D358A
Nup214 NTD D359A
Nup214 NTD V353E
Nup214 NTD E350A/V353E
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Table S3. Ddx19 mutants
NTE mutants Domain 1 mutants Domain 2 mutants
H24A L99A R262A
K26A K100A R266A
K40A L104A* Q269A
K53A Q105A D279A*
R56A Y108A Q286A
K64A Q132A K287A
R67A Q164A K298A
V77A E183A K308A
E78A E191A N326A
R82A K202A K344A
K92A E204A T345A
Q207A V369A
S210A E370A
T220A R372A
L222A V375A*
D223A E377A*
S226A R378A
K227A R380A
I231A E381A
K234A K383A
K235A K385A
K237A* V392A
H253A V412A
Q254A K446A
D255A L452A*
Q256A E457A
I258A
R259A
R259E
R259Q
R259K
*Proteins degraded during purification.
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Table S4. Protein expression and immunofluorescence microscopy constructs
Protein Residues Vector Restriction sites 5, 3 Tags N/C
Expression constructs
Nup214 NTD 1–450 pET28a-PreS NdeI, NotI His6/none
Nup214 mutants 1–450 pET28a-PreS NdeI, NotI His6/none
Nup214 NTD 1–405 1–405 pET28a-PreS NdeI, NotI His6/none
Nup214 NTD 6D7A 1–342,GGSGG, 362–450 pET28a-PreS NdeI, NotI His6/none
Nup214 NTD 1 1–342, 348–450 pET28a-PreS NdeI, NotI His6/none
Nup214 NTD 2 1–347, 352–450 pET28a-PreS NdeI, NotI His6/none
Nup214 NTD 3 1–352, 357–450 pET28a-PreS NdeI, NotI His6/none
GST-6D7A-His6 343–361 pGEX-6P1 EcoRI, NotI GST/His6
Ddx19 Full-length 1–479 pET28a-PreS NdeI, NotI His6/none
Ddx19 NTD 1–300 pET28a-PreS NdeI, NotI His6/none
Ddx19 mutants 1–479 pET28a-PreS NdeI, NotI His6/none
Immunofluorescence microscopy constructs
Nup214 1–2091 pCMV EcoRI, NotI HA
Nup214 NTD 1–450 pCMV EcoRI, NotI HA
Nup214 NTD1–405 1–405 pCMV EcoRI, NotI HA
Nup214 NTD 451–2091 pCMV EcoRI, NotI HA
Nup214 FG 1–1209 pCMV EcoRI, NotI HA
Nup214 NTDFG 451–1209 pCMV EcoRI, NotI HA
Ddx19 Full-length 1–479 pCMV EcoRI, NotI HA
Ddx19 R259A 1–479 pCMV EcoRI, NotI HA
Ddx19 R259K 1–479 pCMV EcoRI, NotI HA
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